Agilent Technologies, Inc. (A) vs Guardant Health, Inc. (GH)

Agilent Technologies, Inc. and Guardant Health, Inc. are both Diagnostics & Research companies. Agilent Technologies, Inc. is the larger, with a market value of $49.0B against $23.9B — 2.0× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Agilent Technologies, Inc. trades at 33.9×. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against 8.60%. Agilent Technologies, Inc. has the higher net margin (19.5% vs −38.3%) and the higher return on invested capital (11.1% vs −129.7%). Across the 18 metrics below, Agilent Technologies, Inc. leads on 10 and Guardant Health, Inc. on 8.

Valuation

Metric A GH Diagnostics & Research median
P/E 33.95 n/m 33.95
P/S 6.61 19.91 4.87
P/B 6.62 n/m 3.12
Price to free cash flow 38.40 n/m 34.02
EV/EBITDA 26.50 n/m 25.20
EV/Sales 6.87 20.29 5.66
Earnings yield 2.95% (1.97%) (1.75%)
Free cash flow yield 2.60% (1.10%) (0.13%)

Profitability

Metric A GH Diagnostics & Research median
Gross margin 53.83% 65.01% 50.89%
Operating margin 22.23% (39.75%) (8.57%)
Net margin 19.53% (38.33%) (6.37%)
Free cash flow margin 17.19% (20.35%) 0.00%
Return on equity 20.97% 171.64% (2.92%)
Return on assets 11.00% (27.95%) (6.71%)
Return on invested capital 11.07% (129.70%) 0.00%

Growth

Metric A GH Diagnostics & Research median
Revenue growth (TTM) 8.60% 42.74% 7.69%
EPS growth (last fiscal year) 3.16% 6.74% —
Revenue growth, 5-year CAGR 5.41% 27.92% 7.40%
Net income growth, 5-year CAGR 12.63% 0.00% 0.00%

Health

Metric A GH Diagnostics & Research median
Debt to equity 0.50 (6.74) 0.11
Current ratio 2.05 4.03 2.02
Net debt to EBITDA 0.71 (0.75) 0.78

Dividend

Metric A GH Diagnostics & Research median
Dividend yield 0.70% — 0.70%
Payout ratio 0.23 0.00 0.00

Size

Metric A GH Diagnostics & Research median
Market cap 49.02b 23.94b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack